SCHEMBL4252665

SCHEMBL4252665

[Os][PH](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.35
TSHR P16473 5/20 0.33
CA1 P00915 3/20 0.33
CA9 Q16790 3/20 0.33
HSD17B10 Q99714 3/20 0.33
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33
CA12 O43570 2/20 0.33
DAO P14920 1/20 0.33
NAPRT Q6XQN6 1/20 0.33
HDAC3 O15379 1/20 0.33
IDO1 P14902 1/20 0.33
ALOX15 P16050 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
TRPA1 O75762 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL304911 0.71 ALDH1A1 (0.39) ALDH1A1TSHRCA1CA9CES2
SCHEMBL5028588 0.69 ALDH1A1 (0.40) ALDH1A1TSHRCA1CA9HSD17B10
SCHEMBL26674 0.69 ALDH1A1 (0.40) ALDH1A1TSHRCA1CA9HSD17B10
SCHEMBL28748541 0.69 ALDH1A1 (0.40) ALDH1A1TSHRCA1CA9HSD17B10
SCHEMBL28993879 0.69 ALDH1A1 (0.37) ALDH1A1TSHRCA1CA9CES2
SCHEMBL29826988 0.69 ALDH1A1 (0.33) ALDH1A1TSHRCA1CA9CA12
SCHEMBL10277371 0.69 ALDH1A1 (0.37) ALDH1A1TSHRCA1CA9CES2
SCHEMBL28738751 0.69 ALDH1A1 (0.37) ALDH1A1TSHRCA1CA9HSD17B10
SCHEMBL15466997 0.69 ALDH1A1 (0.37) ALDH1A1TSHRCA1CA9CES2
Bromide SCHEMBL9723310 0.69 ALDH1A1 (0.37) ALDH1A1TSHRCA1CA9CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107429210-B Medical device, fluorine-containing cyclic olefin polymer composition, and cell culture method 三井化学株式会社 2021-05-28 CN disclosed
CN-106661537-B Medical apparatus, cell culture processes, fluorine-containing cyclic olefin polymer, fluorine-containing cyclic olefin polymer composition and culture cell 三井化学株式会社 2019-06-25 CN disclosed
CN-107429210-A Medical apparatus, fluorine-containing cyclic olefin polymer, fluorine-containing cyclic olefin polymer composition and cell culture processes 三井化学株式会社 2017-12-01 CN disclosed
CN-106661537-A Medical device, method for culturing cells, fluorine-containing cyclic olefin polymer, fluorine-containing cyclic olefin polymer composition, and cultured cells 三井化学株式会社 2017-05-10 CN disclosed
CN-105164559-A Optical film MITSU CHEMICALS INC KEIO UNIVERSITY 2015-12-16 CN disclosed
CN-102906150-B Optical material and molded article thereof MITSU CHEMICALS INC 2014-11-19 CN disclosed
CN-102574989-B Polymer purification method and polymer MITSUI CHEMICALS INC 2014-03-26 CN disclosed
CN-102334177-B Transfer body and method for producing same MITSU CHEMICALS INC 2014-01-08 CN disclosed
CN-102476061-B Alkene double decomposition catalyst and preparation method thereof CHINA PETROLEUM & CHEMICAL 2013-09-11 CN disclosed
CN-102482364-B Fluorinated cyclic olefin polymer composition, transfer body obtained from the composition, and method for producing the transfer body MITSU CHEMICALS INC 2013-08-28 CN disclosed
CN-102334177-A Transfer body and method for producing same MITSUI CHEMICALS INC 2012-01-25 CN disclosed
CN-101490126-B Ring-opening metathesis polymer, hydrogenated product thereof, process for producing the same, and use thereof MITSUI CHEMICALS INC 2011-09-14 CN disclosed
CN-101490126-A Ring-opening metathesis polymer, hydrogenated product thereof, process for producing the same, and use thereof MITSUI CHEMICALS INC (JP) 2009-07-22 CN disclosed
US-20090124772-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY USING THE SAME, RING-OPENING METATHESIS POLYMER OBTAINABLE WITH THE METATHESIS CATALYST, AND PROCESS FOR PRODUCING THE POLYMER MITSUI CHEMICALS, INC. (JP) 2009-05-14 US disclosed
CN-101291944-A Process for producing organic transition metal complex compound, metathesis catalyst produced by the process, metathesis polymer formed by ring opening polymerization with the same, and process for pr MITSUI CHEMICALS INC (JP) 2008-10-22 CN disclosed
EP-1950216-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY THE PROCESS, METATHESIS POLYMER FORMED BY RING OPENING POLYMERIZATION WITH THE SAME, AND PROCESS FOR PRODUCING POLYMER WITH THE SAME Mitsui Chemicals, Inc. (JP) 2008-07-30 EP disclosed
CN-1249119-C Hydrogenated ring-opening metathesis copolymer and process for producing the same MITSUI CHEMICALS INC (JP) 2006-04-05 CN disclosed
CN-1233685-C Fluorinated cycloolefin polymer, cycloolefin monomer thereof, preparation method of polymer and application of polymer MITSUI CHEMICALS INC (JP) 2005-12-28 CN disclosed
CN-1462286-A Fluorinated cycloolefin polymers, its cycloolefin monomers processes for preparation of polymers thereof and use of the same MITSUI CHEMICALS INC (JP) 2003-12-17 CN disclosed
CN-1380888-A Hydrogenated ring-opening metathesis polymer and process for producing the same MITSUI CHEMICALS INC (JP) 2002-11-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124772-A1 PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY USING THE SAME, RING-OPENING METATHESIS POLYMER OBTAINABLE WITH THE METATHESIS CATALYST, AND PROCESS FOR PRODUCING THE POLYMER PORCN, ICMT, ME1 ALDH1A1 3315/4885TSHR 4344/4885CA1 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.